In a report released yesterday, Ashish Sabadra from RBC Capital reiterated a Hold rating on Clarivate (CLVT – Research Report), with a price target of $8.00. The company’s shares opened today at $7.14.
Sabadra covers the Financial sector, focusing on stocks such as Moody’s, Dun & Bradstreet Holdings, and Automatic Data Processing. According to TipRanks, Sabadra has an average return of 1.7% and a 52.31% success rate on recommended stocks.
The word on The Street in general, suggests a Hold analyst consensus rating for Clarivate with a $8.60 average price target.
See the top stocks recommended by analysts >>
The company has a one-year high of $11.99 and a one-year low of $6.07. Currently, Clarivate has an average volume of 6.67M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Clarivate (CLVT) Company Description:
Clarivate Analytics Plc provides trusted insights and analytics to accelerate the pace of innovation. Its solutions include scientific and research, patent intelligence and compliance standards, pharmaceutical and biotech intelligence and trademark, domain and brand protection. The company product portfolio includes Life Science, Web of Science, Cortellis, Derwent, CompuMark, MarkMonitor and Techstreet. It helps clients to reduce the time from new ideas to life changing innovations. The company was founded in 1864 and is headquartered in St. Helier, Jersey.
Read More on CLVT:
- Clarivate assumed at Buy from Hold at Jefferies
- Clarivate selected by Yale to provide library services, discovery platforms
- Clarivate price target lowered to $8 from $10 at Citi
- Clarivate creates Academia & Government Innovation Incubator, acquires Alethea
- Clarivate terminates tax benefits preservation plan
